EUVIMEDEUVIMED entdecken
Open Access

Coronary Artery Disease and Axillary Lymphadenopathy Post COVID-19 Vaccine Administration: Insights from Tl-201 Myocardial Perfusion Imaging

Thomas Yen-Ting Chen, Ting-Chun Tseng, Daniel Hueng-Yuan Shen, Yow-Ling Shiue, Jen-Hau Yang, Hung-Pin Chan

In Vivo · 2026

DOI: 10.21873/invivo.14278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2026. Verfasst von Thomas Yen-Ting Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Coronary Artery Disease, COVID-19 Vaccines, Myocardial Perfusion Imaging, Lymphadenopathy. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The global COVID-19 vaccination campaign has raised concerns about potential side effects, including cardiac involvement or axillary lymphadenopathy. This study investigated the relationship between COVID-19 vaccination and thallium-201 myocardial perfusion imaging (Tl-201 MPI) findings, aiming to elucidate the impact of the vaccine impact on cardiac health. PATIENTS AND METHODS: This retrospective analysis enrolled patients referred for MPI examination post-COVID-19 vaccination between June 2021 and January 2022. Eligible participants included symptomatic individuals without prior coronary artery disease (CAD) or with stable CAD, experiencing symptoms within one-month post-vaccination. MPI was conducted post dipyridamole-stress testing, and positive stress test results were further evaluated by cardiac catheterization. The association between vaccination and MPI results, including axillary lymphadenopathy presence, was assessed. RESULTS: Sixty-four patients were included, with a mean age of 54.7 years, and a predominance of males (64.3%). A notable incidence of positive MPI findings and axillary lymphadenopathy was observed, particularly in patients vaccinated with mRNA vaccines. Among the 15 patients with positive MPI, visible axillary lymphadenopathy was observed in 4 cases (26.7%), compared with 6 of 49 patients (12.2%) with negative MPI. Although this difference was not statistically significant, it suggests a possible trend toward a higher prevalence in the MPI-positive subgroup. Most patients with positive MPI findings had received the Moderna vaccine. CONCLUSION: Our findings indicate a potential link between mRNA COVID-19 vaccination and cardiac issues detected via MPI, as well as an increase in axillary lymphadenopathy. Although further prospective studies are warranted to establish causality, our findings underscore the importance of post-vaccination monitoring, particularly in symptomatic patients, and the need of continued efforts to comprehensively assess vaccine safety to help reduce mortality rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseCOVID-19 VaccinesMyocardial Perfusion ImagingLymphadenopathyThallium RadioisotopesCOVID-19HumansMaleFemaleMiddle AgedRetrospective StudiesVaccinationAgedAxillaSARS-CoV-2Adult

Stichwörter der Autor:innen

COVID-19 vaccinationaxillary lymphadenopathycoronary artery diseasemRNA vaccinesmyocardial perfusion imagingnuclear cardiologythallium-201

Substanzen

COVID-19 VaccinesThallium RadioisotopesThallium-201

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.
  • Department of Otolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.
  • Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.
  • Institute of Biomedical Sciences, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan, R.O.C.
  • Institute of Precision Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan, R.O.C.
  • Doctoral Program of Clinical and Experimental Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan, R.O.C.

Zitieren

APA

Chen, T. Y., Tseng, T. C., Shen, D. H., Shiue, Y. L., Yang, J. H., & Chan, H. P. (2026). Coronary Artery Disease and Axillary Lymphadenopathy Post COVID-19 Vaccine Administration: Insights from Tl-201 Myocardial Perfusion Imaging. In Vivo. https://doi.org/10.21873/invivo.14278

Vancouver

Chen TY, Tseng TC, Shen DH, Shiue YL, Yang JH, Chan HP. Coronary Artery Disease and Axillary Lymphadenopathy Post COVID-19 Vaccine Administration: Insights from Tl-201 Myocardial Perfusion Imaging. In Vivo. 2026. doi:10.21873/invivo.14278

BibTeX
@article{Chen2026,
  author = {Chen, Thomas Yen-Ting and Tseng, Ting-Chun and Shen, Daniel Hueng-Yuan and Shiue, Yow-Ling and Yang, Jen-Hau and Chan, Hung-Pin},
  title = {Coronary Artery Disease and Axillary Lymphadenopathy Post COVID-19 Vaccine Administration: Insights from Tl-201 Myocardial Perfusion Imaging},
  journal = {In Vivo},
  year = {2026},
  doi = {10.21873/invivo.14278}
}
Kostenlos starten →